Director, Patient Marketing

Cambridge, MA (Hybrid)

$210K/yr – $260K/yrDirector/Executive10+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive patient marketing by owning multi-channel campaigns, patient engagement programs, and data-driven optimization while upholding MLR standards and ethical, patient-first communication.

  • Own multi-channel campaigns and patient-facing programs to deliver aligned branding and patient impact.
  • Collaborate with advocacy, compliance, and cross-functional teams to optimize patient communications and engagement.
  • Translate analytics into actionable strategies to improve patient needs understanding and campaign performance.

Job Description

Responsibilities

  • Lead the end-to-end patient marketing strategy.
  • Develop and execute multi-channel campaigns across digital, social, print, and in-person channels, ensuring alignment with overall brand objectives.
  • Drive innovation in digital engagement, including websites, SEO/SEM, social media, email, and emerging technologies.
  • Oversee creation of patient-facing materials and programs, collaborating with creative agencies, digital partners, and cross-functional teams.
  • Spearhead patient ambassador program, collaborating with compliance and legal teams to drive high impact tactics with patients.
  • Manage branded product websites as well as digital interface to patient support services program.
  • Direct research and analytics efforts to understand patient needs, preferences, and digital behaviors.
  • Monitor campaign performance, track KPIs, and optimize programs based on data-driven insights.
  • Ensure all initiatives are compliant with medical/legal/regulatory (MLR) standards and corporate policies.
  • Champion ethical, patient-first communication that supports informed decision-making.
Beam Therapeutics logo

Beam Therapeutics

4.2 Glassdoor

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases.The Beam Team Is:•A community of fearless innovators•Rigorous and honest in our research•Listening with open minds•Committed to each other

Founded in 2017
Cambridge, Massachusetts, USA
574 employees (12 in marketing)
79% recommend to a friend
100% CEO approval

Traffic Signals

Monthly Visitors
35.8K
Traffic Source Mix
Search
38.1%
Direct
22.7%
Referral
3.8%
Social
1.7%
Paid
0.4%

Headcount Trend

Current headcount: ~574

Marketing Team

Marketing Team Size
12 (2% of company)

Funding

Total Funding
$1.3B
Last Raise
$100M
Post IPO Debt, 20 days ago

Funding History

  • Feb 2026
    Post IPO Debt • $100M
  • Mar 2025
    Post IPO Equity • $500M
  • Jan 2021
    Post IPO Equity • $260M

Recent News